Document Detail


An update on the role of leukotrienes in asthma.
MedLine Citation:
PMID:  19915456     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE OF REVIEW: Leukotrienes are lipid mediators involved in the pathogenesis of asthma. There is significant new information about the actions of leukotrienes in asthma and the evolving role of antileukotriene therapies. We review recent findings on regulation of leukotriene synthesis, biological function of leukotrienes in disease models, and use of leukotriene modifiers in clinical practice.
RECENT FINDINGS: Our understanding of the regulation of leukotriene synthesis at a molecular level has greatly advanced. Recent evidence indicates that genetic variation in the leukotriene synthetic pathway affects the clinical response to leukotriene modifiers. The participation of leukotriene B4 in the allergic sensitization process in animal models suggests a larger role for leukotriene B4 in asthma. Preclinical and in-vitro models suggest that the cysteinyl leukotrienes are important in airway remodeling. Leukotrienes are key mediators of exercise-induced bronchoconstriction with recent studies demonstrating that leukotriene modifiers reduce the severity of exercise-induced bronchoconstriction during short-term and long-term use.
SUMMARY: Leukotrienes are clearly involved in airway inflammation and certain clinical features of asthma. Evolving evidence indicates that leukotriene B4 has an important role in the development of asthma and that cysteinyl leukotrienes are key mediators of the airway remodeling process.
Authors:
Teal S Hallstrand; William R Henderson
Related Documents :
12391356 - Exercise-induced temporal lobe epilepsy.
16181256 - Exercise-induced bronchospasm among healthy elite cross country skiers and non-athletic...
11296996 - Exercise training in asthma.
1935276 - The effect of body posture on exercise- and hyperventilation-induced asthma.
9383506 - Renal and hormonal responses to exercise in man at 46 and 37 atmospheres absolute press...
18620466 - Exercise and primary dysmenorrhoea : a comprehensive and critical review of the literat...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current opinion in allergy and clinical immunology     Volume:  10     ISSN:  1473-6322     ISO Abbreviation:  Curr Opin Allergy Clin Immunol     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2009-12-22     Completed Date:  2010-06-09     Revised Date:  2011-07-22    
Medline Journal Info:
Nlm Unique ID:  100936359     Medline TA:  Curr Opin Allergy Clin Immunol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  60-6     Citation Subset:  IM    
Affiliation:
University of Washington, Seattle, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Airway Remodeling / drug effects
Animals
Asthma / drug therapy,  genetics,  immunology*,  physiopathology
Disease Progression
Humans
Leukotriene Antagonists / therapeutic use
Leukotrienes / genetics,  immunology*
Polymorphism, Genetic
Grant Support
ID/Acronym/Agency:
R01 AI042989-10/AI/NIAID NIH HHS; R01 HL089215-02/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Leukotriene Antagonists; 0/Leukotrienes
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The use of a critical care consult team to identify risk for methicillin-resistant Staphylococcus au...
Next Document:  Has the time come to rethink the pathogenesis of asthma?